{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.62"}]}]}],"denomUnitsSelected":"Participants","denoms":[{"counts":[{"groupId":"OG000","value":"56"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"543"}],"units":"Patient-days"}],"groups":[{"description":"Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.","id":"OG000","title":"Granulocyte Arm"}],"paramType":"NUMBER","populationDescription":"The unit of analysis is patient-days where a granulocyte transfusion was scheduled.","reportingStatus":"POSTED","timeFrame":"Measured through study completion","title":"Donor Availability (Proportion of Scheduled Granulocyte Transfusion Days on Which Granulocytes Were Available)","type":"SECONDARY","typeUnitsAnalyzed":"Patient-days","unitOfMeasure":"percentage of available granulocyte days"}